Advanced search
Publication Cover
Drug and Alcohol Review Volume 21, 2002 - Issue 4
Journal homepage
1
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone

Anne Bartu Drug and Alcohol Office; Curtin University of Technology, Perth, Western Australia
,
Nerelie C. Freeman Drug and Alcohol Office, Perth, Western Australia
,
Geoff S. Gawthorne Drug and Alcohol Office, Perth, Western Australia
,
Steve J. Allsop Drug and Alcohol Office; Curtin University of Technology, Perth, Western Australia
&
Allan J. Quigley Next Step Specialist Drug and Alcohol Services, Perth, Western Australia
Pages 335-340 | Published online: 12 Jul 2009

  • Ling W. Naltrexone: the clinical investigator's dilemma. In: Petersen RC, ed. The international challenge of drug abuse. Rockville, MD: National Institute on Drug Abuse 1978: 308-14.
  • Judson BA, Goldstein A. Naltrexone treatment of heroin addiction: one-year follow-up. Drug Alcohol Depend 1984; 13:357-65.
  • Hulse GK, Basso MR. Reassessing naltrexone maintenance as a treatment for illicit heroin users. Drug Alcohol Rev 1999;18:263-9.
  • Foy A, Sadler C, Taylor A. An open trial of naltrexone for opiate dependence. Drug Alcohol Rev 1998;17:167-74.
  • Schifano F, Marra R. Naltrexone for heroin addiction: encouraging results from Italy. Int J Clin Pharmacol Ther Toxicol 1990;28:144-6.
  • Hollister LE, Schwin RL, Kasper P. Naltrexone treatment of opiate-dependent persons. Drug Alcohol Depend 1977;2: 203-9.
  • Tucker TK, Ritter AJ. Naltrexone in the treatment of heroin dependence: a literature review. Drug Alcohol Rev 2000; 19: 73-82.
  • Washton AM, Pottash AC, Gold MS. Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984;45:39-41.
  • Oncken C, van Kirk J, Kranzler HR. Adverse effects of oral naltrexone: analysis of data from two clinical trials. Psychopharm 2001;154:397-402.
  • Greenstein RA, Evans BD, McLellan AT, O'Brien CP. Predictors of favorable outcome following naltrexone treatment. Drug Alcohol Depend 1983; 12:173-80.
  • Capone T, Brahen L, Condren R, et al. Retention and outcome in a narcotic antagonist treatment program. J Clin Psychol 1986;42:825-33.
  • Lerner A, Sigal M, Bacalu A, et al. A naltrexone double-blind placebo controlled study in Israel. Isr J Psychiatry Relat Sci 1992;29(1):36-43.
  • Kosten TR, Jalali B, Steidl JH, Kleber HD. Relationship of marital structure and interactions to opiate abuse relapse. Am J Drug Alcohol Abuse 1987;13:387-99.
  • Hulse GK, Basso MR. The association between naltrexone compliance and daily supervision. Drug Alcohol Rev 2000; 19:41-8.
  • Callahan EJ, Rawson RA, McCleave B, et al. The treatment of heroin addiction: naltrexone alone and with behavior therapy. Int J Addict 1980; 15:795-807.
  • Anton RF, Hogan I, Jalali B, et al. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend 1981;8:157-68.
  • Rounsaville BJ. Can psychotherapy rescue naltrexone treatment of opioid addiction? In: Onken LS, Blaine JD, Boren JJ, eds. Integrating behavioral therapies with medications in the treatment of drug dependence. National Institute on Drug Abuse Research Monograph no. 150. 1995:37-52.
  • Bell JR, Young MR, Masterman SC, et al. A pilot study of naltrexone-accelerated detoxification in opioid-dependence. Med J Aust 1999;171:26-30.
  • Rea F, Bell J, Mattick R, Young M. Naltrexone maintenance treatment: a randomised trial comparing 3 dose levels of naltrexone for the treatment of heroin dependence. Paper presented at the Combined Australian Professional Society on Alcohol and Other Drugs National Methadone Conference; 29-31 October 2001, Sydney, Australia. Sydney: Ad-Image Business Concepts, 2001.
  • Bell J, Kimber J, Mattick RP, et al. Interim clinical guidelines--use of naltrexone in relapse prevention for opioid-dependence (abbreviated version). Available at URL: www.health.gov.au/pubhlth/nds/new/pdf/clinical.pdf
  • Glasgow NJ, Taylor J, Bell JR, et al. Accelerated withdrawal from methadone maintenance therapy using naltrexone and minimal sedation: a case-series analysis. Drug Alcohol Rev 2001;20:213-21.
  • Greenstein RA, O'Brien CP, McLellan AT, et al. Naltrex-one: a short-term treatment for opiate dependence. J Drug Alcohol Abuse 1981;8:291-300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.